Should shocks still be administered during implantable cardioverter-defibrillator insertion?

Heart Rhythm

Volumn 2, Issue 5, 2005, Pages 462-463

  Ideker, Raymond E ^a,b,c,d   Epstein, Andrew E ^a,b   Plumb, Vance J ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d and Radiation Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DEFIBRILLATION; DEFIBRILLATOR; EDITORIAL; HEART DISEASE; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; PRIORITY JOURNAL; SAFETY; SUDDEN DEATH; TREATMENT FAILURE; TREATMENT INDICATION;

DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; VENTRICULAR FIBRILLATION;

EID: 17144413764     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2005.02.004     Document Type: Editorial

References (11)

1. G.H. Bardy K.L. Lee D.B. Mark J.E. Poole D.L. Packer R. Boineau M. Domanski C. Troutman J. Anderson G. Johnson S.E. McNulty N. Clapp-Channing L.D. Davidson-Ray E.S. Fraulo D.P. Fishbein R.M. Luceri J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225-237
2. S.A. Strickberger G.J. Klein Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 44 2004 88-91
3. C.D. Swerdlow Reappraisal of implant testing of implantable cardioverter defibrillators J Am Coll Cardiol 44 2004 92-94
4. A.M. Russo W. Sauer E.P. Gerstenfeld H.H. Hsia D. Lin J.M. Cooper S. Dixit R.J. Verdino H.M. Nayak D.J. Callans V. Patel F.E. Marchlinski Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2 2005 456-461
5. I. Singer D. Lang Defibrillation threshold: Clinical utility and therapeutic implications Pacing Clin Electrophysiol 15 1992 932-949
6. R. Hauser D. Hayes D. Cannom V. Parsonnet S. Furman A. Epstein S. Vlay G. Tyers M. Irwin A. Almquist S. Song J. Hayes L. Kallinen Performance of pacemaker and implantable cardioverter defibrillator pulse generators and leads: Results from the Multicenter Registry XIIth World Congress on Cardiac Pacing and Electrophysiology 2003 173-179
7. A.E. Epstein K.A. Ellenbogen K.A. Kirk G.N. Kay S.M. Dailey V.J. Plumb The High Defibrillation Threshold Investigators Clinical characteristics and outcome of patients with high defibrillation thresholds: A multicenter study Circulation 86 1992 1206-1216
8. T. Guarnieri J.H. Levine L.S.C. Griffith E.P. Veltri When "sudden cardiac death" is not so sudden: Lessons learned from the automatic implantable defibrillator Am Heart J 115 1988 205-207
9. P.A. Brady P.A. Friedman J.M. Trusty S. Grice S.C. Hammill M.S. Stanton High failure rate for an epicardial implantable cardioverter-defibrillator lead: Implications for longterm follow-up of patients with an implantable cardioverter-defibrillator J Am Coll Cardiol 31 1998 616-622
10. B.S. Stambler M.A. Wood R.J. Damiano P.S. Greenway M.L. Smutka K.A. Ellenbogen Sensing/pacing lead complications with a newer generation implantable cardioverter defibrillator: Worldwide experience from the Guardian ATP 4210 clinical trial J Am Coll Cardiol 23 1994 123-132
11. B.S. Stambler K. Ellenbogen X. Zhang T.R. Porter F. Xie R. Malik R. Small M. Burke A. Kaplan L. Nair M. Belz C. Fuenzalida M. Gold C. Love A. Sharma R. Silverman F. Sogade B. Van Natta B.L. Wilkoff Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation J Cardiovasc Electrophysiol 14 2003 1180-1186